Published in Fed Proc on September 01, 1979
Transfer of genetic epilepsy by embryonic brain grafts in the chicken. Proc Natl Acad Sci U S A (1991) 0.81
Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med (1979) 6.00
Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J Immunol (2000) 2.73
CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study. J Clin Immunol (2004) 1.98
Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract. J Immunol (2001) 1.84
Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci U S A (1998) 1.81
CpG DNA induces stronger immune responses with less toxicity than other adjuvants. Vaccine (2000) 1.80
Five-drug therapy for advanced breast cancer: a phase I study. Cancer Chemother Rep (1971) 1.77
Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine. Vaccine (2004) 1.71
CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc Natl Acad Sci U S A (1998) 1.70
Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs. J Immunol (2001) 1.65
DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc Natl Acad Sci U S A (1995) 1.60
The role of CpG dinucleotides in DNA vaccines. Trends Microbiol (1998) 1.57
Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice. Infect Immun (2001) 1.55
Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV. Hepatology (2000) 1.49
CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. J Immunol (1998) 1.48
Hormonal therapy of breast cancer: new approaches and concepts. Ann Intern Med (1978) 1.48
Attaching and effacing Escherichia coli infections in calves, pigs, lambs, and dogs. J Vet Diagn Invest (1989) 1.45
Classical density functional theory of freezing in simple fluids: numerically induced false solutions. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 1.37
The utility of verbal autopsies for identifying HIV-1-related deaths in Haitian children. AIDS (1993) 1.34
Does preservation of the posterior chordae tendineae enhance survival during mitral valve replacement? Ann Thorac Surg (1979) 1.32
Hereditary haemochromatosis mutation frequencies in the general population. J Med Screen (1998) 1.27
Intrahepatic arterial infusion with 5-fluorouracil. Cancer (1971) 1.27
Chemotherapy of large bowel cancer. Cancer (1982) 1.25
Lichtenstein vs anterior preperitoneal prosthetic mesh placement in open inguinal hernia repair: a prospective, randomized trial. Hernia (2003) 1.24
Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates. Mol Med (1999) 1.22
Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants. Vaccine (2000) 1.22
Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys. Vaccine (1999) 1.20
CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal priming. J Immunol (1999) 1.19
Further clinical studies with intrahepatic arterial infusion with 5-fluorouracil. Cancer (1975) 1.16
Trophic effect of ciliary neurotrophic factor on denervated skeletal muscle. Cell (1994) 1.14
CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years. Clin Infect Dis (2008) 1.13
A new single nucleotide polymorphism in CAPN1 extends the current tenderness marker test to include cattle of Bos indicus, Bos taurus, and crossbred descent. J Anim Sci (2005) 1.12
DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. Proc Natl Acad Sci U S A (1996) 1.11
Attaching and effacing Escherichia coli infection as a cause of diarrhea in young calves. J Am Vet Med Assoc (1990) 1.09
Primary squamous cell carcinoma of the breast: sensitivity to cisplatinum-based chemotherapy. J Surg Oncol (1995) 1.08
Functional coordination of multi-agency programs: a symposium. Fam Plann Perspect (1970) 1.07
Daunorubicin and adriamycin in cancer treatment: an analysis of their roles and limitations. Cancer Treat Rep (1979) 1.07
Aerobic bacterial flora of addled raptor eggs in Saskatchewan. J Wildl Dis (1997) 1.07
CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice. FEMS Immunol Med Microbiol (2001) 1.06
Three-dimensional ultrasound examination of the fetal hands: normal and abnormal. Ultrasound Obstet Gynecol (1998) 1.04
Consumer evaluation of beef of known categories of tenderness. J Anim Sci (1997) 1.03
Effects of calpastatin and micro-calpain markers in beef cattle on tenderness traits. J Anim Sci (2006) 1.02
Enhancing vaccines with immune stimulatory CpG DNA. Curr Opin Mol Ther (2001) 1.01
Excretion of Mycobacaterium avium from lesions in the intestine and tonsils of infected swine. Am J Vet Res (1980) 1.01
A practical approach to laparoscopic surgery for malfunctioning peritoneal dialysis catheters. J Laparoendosc Adv Surg Tech A (1998) 1.00
Membrane versus bubble oxygenator for cardiac operations. A prospective randomized study. J Thorac Cardiovasc Surg (1980) 0.99
Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation. Circulation (1990) 0.98
The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants. Vaccine (2001) 0.97
Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study. AJR Am J Roentgenol (1976) 0.97
Adriamycin cardiotoxicity in children: case reports, literature review, and risk factors. Cancer (1977) 0.96
CpG DNA as mucosal adjuvant. Vaccine (1999) 0.96
Neurotrophic effect on isolated chick embryo muscle in culture. Science (1972) 0.96
Assessment of single nucleotide polymorphisms in genes residing on chromosomes 14 and 29 for association with carcass composition traits in Bos indicus cattle. J Anim Sci (2005) 0.95
Recent advances in the study of structural materials compatibility with hydrogen. Adv Mater (2010) 0.95
Priming of immune responses to hepatitis B surface antigen in young mice immunized in the presence of maternally derived antibodies. FEMS Immunol Med Microbiol (2001) 0.95
Diabetic ketoacidosis in a community-based population. Mayo Clin Proc (1980) 0.95
The role of antitumor antibiotics in current oncologic practice. Cancer Chemother Pharmacol (1978) 0.95
Doxorubicin toxicity. Onycholysis, plantar callus formation, and epidermolysis. JAMA (1975) 0.94
National beef tenderness survey - 2006: Assessment of Warner-Bratzler shear and sensory panel ratings for beef from US retail and foodservice establishments. Meat Sci (2007) 0.93
CpG DNA is an effective oral adjuvant to protein antigens in mice. Vaccine (2000) 0.93
DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response. Ann N Y Acad Sci (1995) 0.93
Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants. Vaccine (2001) 0.93
The practice of coronary artery bypass surgery in 1980. J Thorac Cardiovasc Surg (1981) 0.93
The potential of CpG oligodeoxynucleotides as mucosal adjuvants. Crit Rev Immunol (2001) 0.93
Fetal skeletal dysplasia: three-dimensional US--initial experience. Radiology (2000) 0.92
Omental pedicle graft in the management of infected ascending aortic prostheses. Ann Thorac Surg (1987) 0.92
Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides. Antisense Nucleic Acid Drug Dev (1998) 0.92
Developmental changes of acetylcholinesterase and pseudocholinesterase in organotypic cultures of spinal cord. Exp Neurol (1972) 0.92
Is nasogastric tube decompression necessary after major abdominal surgery in children? J Pediatr Surg (1997) 0.92
Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs. Gene Ther (2001) 0.91
The Piromen test: a useful assay of bone marrow granulocyte reserves. Curr Ther Res Clin Exp (1969) 0.91
Adjuvant effects of CpG oligodeoxynucleotides on responses against T-independent type 2 antigens. Immunology (2001) 0.91
Photically-induced retinal damage in diabetic rats. Curr Eye Res (1986) 0.90
Immune response to a hepatitis B DNA vaccine in Aotus monkeys: a comparison of vaccine formulation, route, and method of administration. Mol Med (1998) 0.90
Dental abnormalities as a component of the Laurence-Moon-Bardet-Biedl syndrome. Ophthalmic Paediatr Genet (1990) 0.90
Three-dimensional ultrasound in the evaluation of fetal anomalies. Ultrasound Obstet Gynecol (2000) 0.90
A technique for the creation of long autogenous tissue arterial patches. Cardiovasc Surg (1996) 0.89
Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution. Mol Med (2000) 0.89
DNA-mediated immunization and the energetic immune response to hepatitis B surface antigen. Clin Immunol Immunopathol (1995) 0.89
Triple drug therapy in testicular tumors. Cancer (1969) 0.89
Breast carcinoma metastatic to the stomach. Report of a case in a male and review of an autopsy series. Am J Dig Dis (1968) 0.88
Acute leukemia complicating metastatic breast cancer. Cancer (1973) 0.88
Immunization against hepatitis B virus by mucosal administration of antigen-antibody complexes. Viral Immunol (1998) 0.88
Application of DNA vaccine technology to aquaculture. Adv Drug Deliv Rev (2000) 0.88
Development and evaluation of a cabrito smoked sausage product. Meat Sci (2003) 0.88
Effects of acetyl- -methylcholine on development of acetylcholinesterase and butyrylcholinesterase activities in cultured chick embryonic skeletal muscle. Exp Neurol (1972) 0.88
Designing gene therapy vectors: avoiding immune responses by using tissue-specific promoters. Gene Ther (2001) 0.87
Mini-dystrophin gene transfer in mdx4cv diaphragm muscle fibers increases sarcolemmal stability. Gene Ther (1997) 0.87
Coumarin-induced skin necrosis in a sixteen-year-old girl. Am J Cardiol (1969) 0.87
Long-acting local anesthetic drugs and convulsions with hypoxia and acidosis. Anesthesiology (1982) 0.87
Procoagulant and nerve-blocking effects of DMSO. Ann N Y Acad Sci (1967) 0.87
Severe hypoxia and acidosis following local anesthetic-induced convulsions. Anesthesiology (1980) 0.87
Identification of a transcriptional enhancer within muscle intron 1 of the human dystrophin gene. Hum Mol Genet (1996) 0.87
Tuberculin skin test reactivity among adults infected with human immunodeficiency virus. J Infect Dis (1992) 0.86
Reactive hypoglycemia. JAMA (1980) 0.86
The role of CpG in DNA vaccines. Springer Semin Immunopathol (2000) 0.85
Enteritis secondary to Giardia lamblia in students traveling on tour in Russia. J Am Coll Health Assoc (1972) 0.85
Quantification of oligodeoxynucleotides in human plasma with a novel hybridization assay offers greatly enhanced sensitivity over capillary gel electrophoresis. Oligonucleotides (2005) 0.85
Duplication of 7q31.2----7qter and deficiency of 18qter: report of two patients and literature review. Am J Med Genet (1986) 0.85
Genetic vaccination of rainbow trout against viral haemorrhagic septicaemia virus: small amounts of plasmid DNA protect against a heterologous serotype. Virus Res (1999) 0.85